Ocular Sarcoidosis Open Label Trial of ACTHAR Gel

Cleveland Clinical Foundation
12 Feb, 2019 ,

Treatment with ACTHAR Gel will result in a reduction of ocular inflammation in patients with active ocular sarcoidosis that requires systemic immunosuppressant therapy (hypothesis)

 

Source